Join
Live feed
·
INSIDERFilingvia Quantisnow
Collegium Pharmaceutical Inc. logo

Director Glancy Donovan Michael was granted 17,482 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
COLL· Collegium Pharmaceutical Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COLL (Collegium Pharmaceutical Inc.) and more on Quantisnow.

Director Glancy Donovan Michael was granted 17,482 shares (SEC Form 4) | Quantisnow